Company
Headquarters: Hangzhou, China
Employees: 505
CN¥8.39 Billion
CNY as of Jan. 1, 2025
US$1.15 Billion
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Zhejiang Garden Bio-chemical High-tech Co., Ltd., together with its subsidiaries, manufactures and supplies vitamin D3, cholesterol, and calcifediol in China. Its products have applications in food additives, nutrition and health products, and medicine. The company was founded in 2000 and is based in Dongyang, China.
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | CN¥1.13 B |
| EBITDA | CN¥323.9 M |
| Gross Profit TTM | CN¥655.3 M |
| Profit Margin | 25.11% |
| Operating Margin | 37.03% |
| Quarterly Revenue Growth | 40.00% |
Zhejiang Garden Bio-chemical High-tech Co. Ltd has the following listings and related stock indices.
Stock: SZSE: 300401 wb_incandescent